the sad thing is that this stock should be trading a lot higher than it is just on potential alone .... given the resmed experience there is every reason to think they will ultimately be successful. given the past efforts of management though it will only be when they have a tragically high number of shares on issue. recent changes are welcome, but the fact they are still aligned with old crew is not promising imv. deckchairs and all that. they need to show they can find REAL investors who willpay with REAL cash and not just keep issuing and diluting. yeah biotechs are a long road, but this one should be a lot further down the track in sales, revenue and share price. next two quarterlies will be crucial imv.
KSX Price at posting:
2.0¢ Sentiment: Buy Disclosure: Held
